Everyone’s favorite twerp Martin Shkreli has been hacked—at least on Twitter.
Long before he started drawing public rage for his drug price hike, Shkreli ran a couple of hedge funds.
A uniquely unpleasant way to go.
Turing is just a symptom of much deeper pharmaceutical woes.
A new drug on track for FDA approval offers hope.
The new pill won’t address the majority of women’s issues with sex.
After 30 years, the male birth control shot finally has momentum in the US.
Could electrical currents replace Big Pharma?
The practice is no closed-door secret, and finds brand-name drug manufacturers offering financial incentives--one might call them bribes--to generic manufacturers so as to prevent generic drugs from entering the market.